Tradjenta Tablet, Film Coated
Product Images NDC 0597-0140

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tradjenta (NDC 0597-0140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tradjenta 01

Chemical structure of linagliptin, the active ingredient in Tradjenta 5 mg oral film-coated tablets by Boehringer Ingelheim Pharmaceuticals, Inc. The diagram shows the molecular arrangement including heterocyclic rings and functional groups characteristic of linagliptin.*

FDA Label Image

Tradjenta 02

A line graph comparing the percentage of patients with an event over 3.5 years for placebo versus linagliptin. The x-axis represents time in years, and the y-axis shows the percent of patients with the event. The placebo is represented by a solid line and linagliptin by a dotted line, with accompanying patient risk counts below the x-axis for both groups at various time points.*

FDA Label Image

Tradjenta 03

A Kaplan-Meier curve graph comparing the percentage of patients with an event over 7 years for linagliptin and glimepiride. The x-axis represents time in years, and the y-axis shows the percentage of patients with an event. The solid line represents linagliptin, and the dashed line represents glimepiride. Patient numbers at risk are listed for both groups at various time points along the bottom of the graph.*

FDA Label Image

Tradjenta 04

Tradjenta 5 mg film-coated tablets packaging label, containing oral linagliptin tablets. The label displays the product name, strength, dosage form, and includes a QR code. The labeler is Boehringer Ingelheim Pharmaceuticals, Inc.*

FDA Label Image

Tradjenta 05

Packaging label for Tradjenta 5 mg film-coated tablets containing linagliptin, distributed by Boehringer Ingelheim Pharmaceuticals, Inc. The label states the product is for oral use, providing 100 tablets in 10 blister cards of 10 tablets each. It includes dosage guidance, storage conditions, child-resistant container information, barcodes, and manufacturer details with Boehringer Ingelheim branding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.